| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/28/1994 | CA2147000A1 Ranitidine chewable tablets |
| 04/28/1994 | CA2146999A1 Taste-masking compositions of ranitidine |
| 04/28/1994 | CA2146869A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | CA2146855A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | CA2146639A1 Novel class of phosphocholine derivatives having antifungal activity |
| 04/28/1994 | CA2146536A1 Process for the preparation of drug pellets |
| 04/28/1994 | CA2125784A1 Injectable lecithin gel |
| 04/28/1994 | CA2117310A1 Process and device for encapsulating a substance |
| 04/28/1994 | CA2117309A1 Implantable capsule |
| 04/27/1994 | EP0593897A1 Stabilized solutions of alkylphosphocholine in glycerolalkylether |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593807A1 Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
| 04/27/1994 | EP0593624A1 Improvements in or relating to contrast agents. |
| 04/27/1994 | EP0593601A1 Novel compositions based on taxane class derivatives |
| 04/27/1994 | EP0593573A1 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
| 04/27/1994 | EP0593562A1 Tropical composition containing penciclovir |
| 04/27/1994 | EP0484529B1 Skin cream preparation for external use |
| 04/27/1994 | EP0477209B1 A preparation for the treatment of fungal infections |
| 04/27/1994 | EP0462145B1 Covalent conjugates of lipid and oligonucleotide |
| 04/27/1994 | EP0455725B1 Pharmaceutical formulations of plasminogen activator proteins |
| 04/27/1994 | EP0445131B1 Liposomes |
| 04/27/1994 | EP0408546B1 Improvements relating to drug delivery systems |
| 04/27/1994 | CN1085805A Vaccine compositions |
| 04/27/1994 | CN1085804A Stabilized somatotropin for parenterai administration |
| 04/26/1994 | US5306838 Cosmetics, storage stability |
| 04/26/1994 | US5306809 Acid-labile linker molecules |
| 04/26/1994 | US5306508 Red blood cell surrogate |
| 04/26/1994 | US5306505 Controlled drug delivery tablets |
| 04/26/1994 | US5306504 Water insoluble, water swellable crosslinked ampholyte salt of hydrolyzed polyvinylpyrrolidone and multifunctional amine containing polymer |
| 04/26/1994 | US5306501 Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
| 04/26/1994 | US5306492 Oligosaccharide conjugated to carrier protein |
| 04/26/1994 | US5306483 Phospholipid delivery system |
| 04/26/1994 | US5306482 Benz(alk or eth)orium chloride |
| 04/26/1994 | US5305757 Gas filled liposomes and their use as ultrasonic contrast agents |
| 04/25/1994 | CA2109026A1 Oral medicament form |
| 04/24/1994 | CA2081281A1 Activation of glucuronide prodrugs by ligand-beta-glucuronidase conjugates for chemotherapy |
| 04/23/1994 | CA2108820A1 Parenteral solutions for diclofenac salts |
| 04/21/1994 | DE4234537A1 A compound a polymeric bile acid and insulin - useful in the prodn. of a medicament for diabetes mellitus, for nasal admin. |
| 04/20/1994 | EP0592904A1 Topical stable compositions with good active agent release capability and containing at least a lipophilized macrolide antibiotic |
| 04/20/1994 | EP0592594A1 Colestipol hydrochloride high-content tablets |
| 04/20/1994 | EP0592569A1 Composition and method for transdermal delivery of diclofenac |
| 04/20/1994 | EP0592562A1 Bmp-9 compositions |
| 04/20/1994 | EP0592511A1 Sequence-specific binding polymers for duplex nucleic acids. |
| 04/20/1994 | EP0592446A1 Loading technique for preparing drug containing liposomes. |
| 04/20/1994 | EP0539408B1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 04/20/1994 | EP0460020B1 Drug delivery compositions |
| 04/20/1994 | CN1085598A Method for preparing cocoa butter substitute with tea oil as raw material |
| 04/20/1994 | CN1085450A Vaccines |
| 04/19/1994 | US5304610 Amphoteric copolymer derived from vinylpyridine and acetoxystyrene |
| 04/19/1994 | US5304571 Unbuffered premixed ranitidine formulation |
| 04/19/1994 | US5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 04/19/1994 | US5304382 Ferritin analogs |
| 04/19/1994 | US5304381 Stabilization of polyprenyl compound |
| 04/19/1994 | US5304379 A reservoir consists of tetracaine and metabolic modulator to inhibit monoamine oxidase enzyme |
| 04/19/1994 | US5304377 Blend of polylactic acid and glycolic acid copolymer |
| 04/19/1994 | US5304375 Nonoxinol-9 solubilized in polysiloxane having hydroxyl groups or polyether functionality |
| 04/19/1994 | US5304325 Emulsions of fluorochemical, water, surfactant; synthetic blood |
| 04/19/1994 | CA1328634C Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| 04/19/1994 | CA1328620C Stabilized peroxide solutions |
| 04/19/1994 | CA1328614C Preservative system for ophthalmics formulations |
| 04/19/1994 | CA1328609C Antibiotic-polymer compositions |
| 04/14/1994 | WO1994008050A1 Nucleic acid ligands and methods for producing the same |
| 04/14/1994 | WO1994007999A1 Chitosan matrices for encapsulated cells |
| 04/14/1994 | WO1994007830A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 04/14/1994 | WO1994007540A1 X-ray contrast medium for examining large and small intestines |
| 04/14/1994 | WO1994007537A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 04/14/1994 | WO1994007536A2 Alginate-bioactive agent conjugates |
| 04/14/1994 | WO1994007530A1 Vaccines and antigenic conjugates |
| 04/14/1994 | WO1994007529A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/14/1994 | WO1994007510A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 04/14/1994 | WO1994007505A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 04/14/1994 | WO1994007504A1 New pharmaceutical formulations of spiramycine |
| 04/14/1994 | WO1994007493A1 Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
| 04/14/1994 | WO1994007488A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 04/14/1994 | WO1994007484A1 Pharmaceutical solutions and emulsions containing taxol |
| 04/14/1994 | WO1994007478A1 Topical pharmaceutical compositions |
| 04/14/1994 | WO1994007477A1 Taste masking of thymol |
| 04/14/1994 | WO1994007473A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGFαPE40ab |
| 04/14/1994 | WO1994007472A1 Pharmaceutical compositions containing nonionic surfactants |
| 04/14/1994 | WO1994007466A1 Compositions for treatmewnt of inflamed tissues |
| 04/14/1994 | WO1994007373A1 Surface treatment composition |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | WO1994005332A3 Glycolation of glycosylated macromolecules |
| 04/14/1994 | CA2146572A1 Controlled-ph formulation for intravesicular instillation of tgfpe40 ab |
| 04/14/1994 | CA2146448A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 04/14/1994 | CA2146324A1 Pharmaceutical composition for the site-specific release of clot-dissolving protein and method for the preparation thereof |
| 04/14/1994 | CA2146251A1 New pharmaceutical spiramycin formulations |
| 04/14/1994 | CA2145763A1 Pharmaceutical compositions containing nonionic surfactants |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2145502A1 Alginate-bioactive agent conjugates |
| 04/14/1994 | CA2145391A1 Vaccines and antigenic conjugates |
| 04/14/1994 | CA2145205A1 Surface treatment composition |
| 04/14/1994 | CA2144059A1 Chitosan matrices for encapsulated cells |
| 04/13/1994 | EP0592380A1 Ointment for treatment of epithelial lesions |
| 04/13/1994 | EP0592169A1 Stabilised magnesium hydroxide slurries |
| 04/13/1994 | EP0592130A2 Hard capsules |
| 04/13/1994 | EP0591710A1 Injection solutions containing mesna |
| 04/13/1994 | EP0591492A1 A pharmaceutical composition containing a defined lipid system |
| 04/13/1994 | EP0591483A1 Albumin-iodine preservation of blood, tissues and biological fluids |
| 04/13/1994 | EP0591452A1 Multiple emulsions and methods of preparation |